EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Summary of Research: Aflibercept 8 mg versus Faricimab Treat‑and‑Extend for Diabetic Macular Edema or Neovascular Age‑Related Macular Degeneration: A Bayesian Fixed‑Effect Network Meta‑analysis of Clinical Trials

Scott M Friedman, Yingxin Xu, Steven Sherman, Andreas Kuznik, Ali Mojebi, Sam Keeping, Keith Chan, Theodore Leng, Nimesh A Patel

Ophthalmology and Therapy · 2026-08 · 15 (8) · 2515-2518

DOI: 10.1007/s40123-026-01434-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Ophthalmology and Therapy, online erschienen am 23.06.2026. Verfasst von Scott M Friedman und 8 weiteren Autor:innen. Beteiligte Einrichtung: Florida Retina Consultants, Lakeland, FL, USA. smfriedman83@hotmail.com. Die Arbeit nennt 1 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Regeneron Pharmaceuticals.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

AfliberceptAnti-VEGF therapyFaricimabNetwork meta-analysis

Autor:innen und Institutionen

  • Florida Retina Consultants, Lakeland, FL, USA. smfriedman83@hotmail.com.
  • Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.
  • Precision AQ, Vancouver, BC, Canada.
  • Byers Eye Institute at Stanford University, Stanford University School of Medicine, Palo Alto, CA, USA.
  • Harvard Medical School, Boston, MA, USA.
  • Massachusetts Eye and Ear and Massachusetts General Hospital, Boston, MA, USA.

Förderung

  • Regeneron Pharmaceuticals

Zitieren

APA

Friedman, S. M., Xu, Y., Sherman, S., Kuznik, A., Mojebi, A., Keeping, S., Chan, K., Leng, T., & Patel, N. A. (2026). Summary of Research: Aflibercept 8 mg versus Faricimab Treat‑and‑Extend for Diabetic Macular Edema or Neovascular Age‑Related Macular Degeneration: A Bayesian Fixed‑Effect Network Meta‑analysis of Clinical Trials. Ophthalmology and Therapy, 15(8), 2515-2518. https://doi.org/10.1007/s40123-026-01434-w

Vancouver

Friedman SM, Xu Y, Sherman S, Kuznik A, Mojebi A, Keeping S, et al. Summary of Research: Aflibercept 8 mg versus Faricimab Treat‑and‑Extend for Diabetic Macular Edema or Neovascular Age‑Related Macular Degeneration: A Bayesian Fixed‑Effect Network Meta‑analysis of Clinical Trials. Ophthalmology and Therapy. 2026;15(8):2515-2518. doi:10.1007/s40123-026-01434-w

BibTeX
@article{Friedman2026,
  author = {Friedman, Scott M and Xu, Yingxin and Sherman, Steven and Kuznik, Andreas and Mojebi, Ali and Keeping, Sam and Chan, Keith and Leng, Theodore and Patel, Nimesh A},
  title = {Summary of Research: Aflibercept 8 mg versus Faricimab Treat‑and‑Extend for Diabetic Macular Edema or Neovascular Age‑Related Macular Degeneration: A Bayesian Fixed‑Effect Network Meta‑analysis of Clinical Trials},
  journal = {Ophthalmology and Therapy},
  year = {2026},
  volume = {15},
  number = {8},
  pages = {2515--2518},
  doi = {10.1007/s40123-026-01434-w}
}
Kostenlos starten →